The effect of blockade of the CD11/CD18 integrin receptor on infarct size in patients with acute myocardial infarction treated with direct angioplasty: the results of the HALT-MI study

This publication has 29 references indexed in Scilit:

• The appearance of L-selectin^lowpolymorphonuclear leukocytes in the circulating pool of peripheral blood during myocardial infarction correlates with neutrophilia and with the size of the infarct
  Clinical Cardiology, 1999
• Adenosine as an adjunct to thrombolytic therapy for acute myocardial infarction
  Journal of the American College of Cardiology, 1999
• Hu23F2G, an Antibody Recognizing the Leukocyte CD11/CD18 Integrin, Reduces Injury in a Rabbit Model of Transient Focal Cerebral Ischemia
  Experimental Neurology, 1998
• Reperfusion injury: a review of the pathophysiology, clinical manifestations and therapeutic options
  International Journal of Cardiology, 1997
• An anti-CD18 antibody limits infarct size and preserves left ventricular function in dogs with ischemia and 48-hour reperfusion
  Journal of the American College of Cardiology, 1996
• A chimeric IgG4 monoclonal antibody directed against CD18 reduces infarct size in a primate model of myocardial ischemia and reperfusion
  Journal of the American College of Cardiology, 1995
• Myocardium at risk and infarct size after thrombolytic therapy for acute myocardial infarction: Implications for the design of randomized trials of acute intervention
  Journal of the American College of Cardiology, 1994
• Indications for fibrinolytic therapy in suspected acute myocardial infarction: collaborative overview of early mortality and major morbidity results from all randomised trials of more than 1000 patients
  Published by Elsevier ,1994
• Reperfusion induced injury: manifestations, mechanisms, and clinical relevance
  Cardiovascular Research, 1992
• Myocardial reperfusion: a double-edged sword?
  Journal of Clinical Investigation, 1985